Naturhouse Health Statistics

Total Valuation

BME:NTH has a market cap or net worth of EUR 104.91 million. The enterprise value is 81.75 million.

Market Cap	104.91M
Enterprise Value	81.75M

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025.

Earnings Date	May 13, 2025
Ex-Dividend Date	Apr 3, 2025

Share Statistics

BME:NTH has 59.95 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	59.95M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.14%
Float	13.12M

Valuation Ratios

The trailing PE ratio is 10.77 and the forward PE ratio is 10.29.

PE Ratio	10.77
Forward PE	10.29
PS Ratio	2.10
PB Ratio	3.80
P/TBV Ratio	3.86
P/FCF Ratio	7.19
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.02, with an EV/FCF ratio of 5.60.

EV / Earnings	8.39
EV / Sales	1.64
EV / EBITDA	5.02
EV / EBIT	5.74
EV / FCF	5.60

Financial Position

The company has a current ratio of 2.09, with a Debt / Equity ratio of 0.17.

Current Ratio	2.09
Quick Ratio	1.91
Debt / Equity	0.17
Debt / EBITDA	0.28
Debt / FCF	0.31
Interest Coverage	22.09

Financial Efficiency

Return on equity (ROE) is 33.98% and return on invested capital (ROIC) is 25.57%.

Return on Equity (ROE)	33.98%
Return on Assets (ROA)	18.02%
Return on Invested Capital (ROIC)	25.57%
Return on Capital Employed (ROCE)	43.61%
Revenue Per Employee	253,274
Profits Per Employee	49,457
Employee Count	207
Asset Turnover	1.02
Inventory Turnover	4.97

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +7.62% in the last 52 weeks. The beta is 0.86, so BME:NTH's price volatility has been lower than the market average.

Beta (5Y)	0.86
52-Week Price Change	+7.62%
50-Day Moving Average	1.76
200-Day Moving Average	1.73
Relative Strength Index (RSI)	51.77
Average Volume (20 Days)	21,268

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BME:NTH had revenue of EUR 49.90 million and earned 9.74 million in profits. Earnings per share was 0.16.

Revenue	49.90M
Gross Profit	35.72M
Operating Income	14.16M
Pretax Income	13.60M
Net Income	9.74M
EBITDA	14.71M
EBIT	14.16M
Earnings Per Share (EPS)	0.16

Full Income Statement

Balance Sheet

The company has 27.74 million in cash and 4.58 million in debt, giving a net cash position of 23.17 million or 0.39 per share.

Cash & Cash Equivalents	27.74M
Total Debt	4.58M
Net Cash	23.17M
Net Cash Per Share	0.39
Equity (Book Value)	27.60M
Book Value Per Share	0.46
Working Capital	17.95M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 15.33 million and capital expenditures -729,000, giving a free cash flow of 14.60 million.

Operating Cash Flow	15.33M
Capital Expenditures	-729,000
Free Cash Flow	14.60M
FCF Per Share	0.24

Full Cash Flow Statement

Margins

Gross margin is 71.58%, with operating and profit margins of 28.38% and 19.53%.

Gross Margin	71.58%
Operating Margin	28.38%
Pretax Margin	27.25%
Profit Margin	19.53%
EBITDA Margin	29.49%
EBIT Margin	28.38%
FCF Margin	29.25%

Dividends & Yields

This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 11.43%.

Dividend Per Share	0.20
Dividend Yield	11.43%
Dividend Growth (YoY)	33.33%
Years of Dividend Growth	1
Payout Ratio	92.37%
Buyback Yield	n/a
Shareholder Yield	11.43%
Earnings Yield	9.29%
FCF Yield	13.91%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BME:NTH has an Altman Z-Score of 5.17.

Altman Z-Score	5.17
Piotroski F-Score	n/a